Document Detail


Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow.
MedLine Citation:
PMID:  19809204     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Slow coronary flow (SCF) is the phenomenon of slow progression of angiographic contrast in the coronary arteries in the absence of stenosis in the epicardial vessels in some patients presenting with chest pain. There are no definite treatment modalities for patients with SCF. Our aim was to investigate the efficacy of nebivolol in patients with slow coronary flow by monitoring its effects on endothelial function and different markers of inflammation. Forty-two patients (16 females, 26 males; mean age, 55 +/- 10) with slow coronary flow (SCF) were included in the study. After baseline assessment, the patients were administered nebivolol 5 mg once daily. After 12 weeks of nebivolol therapy, the biochemical and ultrasonographic examinations were repeated. Chest pain relief was detected in 38 patients after treatment (90%). Systolic and diastolic blood pressure and high sensitive CRP were significantly decreased after nebivolol therapy. Among brachial artery dilation variables that reflect endothelial function, basal resistive index (RI), post-flow mediated dilation RI, and post-nitrate mediated dilation RI were significantly decreased after therapy. Nebivolol is effective at improving endothelial function in patients with SCF. It controls chest pain, decreases CRP, and has favorable effects on brachial artery dilation variables in patients with coronary slow flow.
Authors:
Sinan Albayrak; Serkan Ordu; Hatice Yuksel; Hakan Ozhan; Omer Yazgan; Mehmet Yazici
Related Documents :
2376074 - Profound spatial heterogeneity of coronary reserve. discordance between patterns of res...
2919764 - Influence of nifedipine on systemic and regional hemodynamics during adenosine-induced ...
22336894 - Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integratin...
3719914 - Effects of endotoxin on coronary vascular resistance in the isolated blood-perfused rab...
15888094 - A short period of apnoea causes a marked increase in coronary flow velocity: a transtho...
2379334 - Blood loss during liposuction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International heart journal     Volume:  50     ISSN:  1349-2365     ISO Abbreviation:  -     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-10-07     Completed Date:  2009-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244240     Medline TA:  Int Heart J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  545-53     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Düzce Medical School, Düzce University, Düzce, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*
Aged
Benzopyrans / pharmacology*
Chest Pain / physiopathology,  radiography
Coronary Angiography
Coronary Vessels / physiopathology
Endothelium, Vascular / physiopathology
Ethanolamines / pharmacology*
Female
Humans
Male
Middle Aged
Prospective Studies
Vasodilation / drug effects*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Benzopyrans; 0/Ethanolamines; 99200-09-6/nebivolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute myocardial infarction: the enduring challenge for cardiac protection and survival.
Next Document:  Additive antihypertensive and antihypertrophic effects of long-acting ca blockers in uncontrolled hy...